Over 250 branded drugs in the U.S. will see price increases starting Jan. 1, 2025, with most hikes below 10% and a median increase of 4.5%.
Key companies like Pfizer, Bristol Myers Squibb, and Sanofi are raising prices on treatments for COVID-19, cancer, and vaccines, citing R&D costs and inflation.
Some prices, such as Merck’s diabetes drugs, will be reduced.
Critics highlight that U.S. drug prices remain the highest globally, while manufacturers face pressure to moderate year-over-year price hikes.
Demoralize these assholes with shrines to Luigi outside their workplace. Pamphlet them with the good news of Luigi as they go to work. I think 2/3 of America found their religion that fateful day and they should know that.
I'm back to complain about Australians looking at Medicare through rose tinted glasses, when it still has a lot left to be desired.
PBS is one of the better parts of Medicare, however, there is very often a gap fee, even for PBS medication, unless you qualify for a health care card. Which is great because we're taking care of people who can't afford it, and the gap fee is still mostly fine, in most cases.
I mean, look at the sign, has an Asterix right there.
However, the rest of Medicare is more and more resembling a two-tiered system where you get to skip the queue if you have the means to pay, and you get a tax break to do so 👍 and of course, can't forget our luxury bones which still aren't covered.
Please do not vote for the LNP, I beg you.
Medicare is not that great compared to what we could afford as one of the richest countries per capita in the world. Only in comparison to the shitshow in the US.
That's a bold move. We should get confirmation that the CEOs are aware of this. We should also get confirmation that they signed off on this. And a photo op with said people too, you know, for prosperity...
"But did you think those boomers needed to pay $5 less for medicine? That's a win! Now let's have millions die of preventable illness because healthcare is a heavy tax burden on the middle class."
Now now, I think you know these fine American institutions won’t be passing up another opportunity to raise prices once those tariffs hit. This is a double dip.
Slight tangent: a drug I’m on for a nervous system condition used to cost me $400 a month copay when I lived in the states. Now it’s €0.37 here in Portugal. Yup. 37 cents.
If the pharmaceutical executives are so confident that making these types decisions is necessary....Then why won't they get on a podium in a public space on live TV and explain they're reasoning to the very people it's going to effect the most?
If it's really that important there should be no issue with the public's response.